Skip to the page

Data / Drug companies / Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited: 77 products in the FDA NDC directory, labeler code 14593

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Emcure Pharmaceuticals Limited (labeler code 14593) lists 77 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 76 bulk ingredients, 1 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on February 23, 2026.

The request: Watch Emcure Pharmaceuticals Limited (FDA labeler code 14593): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
14593
Products in commercial distribution
77
Packages
252
Finished drugs by generic name
1
Prescription products
1
Over the counter products
0
Controlled substance products
Schedule III 1, Schedule IV 1
Flagged as original packager
1 of 1 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
June 27, 2008
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients7698.7%
Generic drugs (ANDA)11.3%

Products by type

TypeProductsShare
Bulk ingredients7698.7%
Prescription drugs11.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Tranexamic acid139

Dosage forms

Dosage formProductsShare
Powder7394.8%
Liquid33.9%
Injection, solution11.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Arsenic trioxide14593-936PowderBulk ingredientsFebruary 23, 2026
Zoledronic acid14593-942PowderBulk ingredientsFebruary 9, 2026
Sodium nitroprusside14593-909PowderBulk ingredientsDecember 25, 2025
Ropivacaine hydrochloride14593-907PowderBulk ingredientsNovember 21, 2025
Tapinarof14593-953PowderBulk ingredientsNovember 19, 2025
Dydrogesterone14593-954PowderBulk ingredientsJuly 24, 2025
Benazepril hydrochloride14593-952PowderBulk ingredientsFebruary 5, 2025
Lenacapavir sodium14593-955PowderBulk ingredientsJanuary 5, 2025
Hydroxyzine pamoate14593-951PowderBulk ingredientsDecember 20, 2024
Tranexamic Acid14593-318Injection, solutionGeneric drugs (ANDA)October 28, 2024
Atazanavir sulfate14593-806PowderBulk ingredientsDecember 26, 2023
Etodolac14593-875PowderBulk ingredientsDecember 25, 2023
Memantine hydrochloride14593-870PowderBulk ingredientsDecember 25, 2023
Dronedarone hydrochloride14593-866PowderBulk ingredientsDecember 25, 2023
Busulfan14593-865PowderBulk ingredientsDecember 25, 2023
Zolmitriptan14593-863PowderBulk ingredientsDecember 25, 2023
Felbamate14593-862PowderBulk ingredientsDecember 25, 2023
Esomeprazole sodium14593-857PowderBulk ingredientsDecember 25, 2023
Zileuton14593-854PowderBulk ingredientsDecember 25, 2023
Dolasetron mesylate14593-849PowderBulk ingredientsDecember 25, 2023
Irinotecan hcl14593-828PowderBulk ingredientsDecember 25, 2023
Gemcitabine hcl14593-827PowderBulk ingredientsDecember 25, 2023
Protriptyline hcl14593-825PowderBulk ingredientsDecember 25, 2023
Foscarnet sodium14593-925PowderBulk ingredientsDecember 22, 2023
Fingolimod hydrochloride14593-902PowderBulk ingredientsDecember 22, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.